Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：3.9 Date：2026-02-13

scientific reports

PERK inhibition attenuates multi-program cell death through Nrf2/HO-1 activation in diabetic retinopathy with integrated proteomics and functional validation in HRECs

Products： ELK4775
IF：3.9 Date：2026-03-13

Biomedicines

Combined Therapy with Pirfenidone, Metformin, and Mesenchymal Stem Cells Attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats

Products： EP014
IF：3.9 Date：2026-02-17

Biomedicines

Upregulated ZBP1 Is Associated with B-Cell Dysregulation in Systemic Lupus Erythematosus

Products： ELK10232、 ELK1390
IF：3.9 Date：2026-01-29

scientific reports

Potential predictors of COVID-19 disease infection and severity in Egypt

Products： ELK1156、 ELK1270

< Page of 441 >